#longevity

A subscriber-only MIT Technology Review ebook revisits R3 Bio, a startup described as pitching 'brainless clones' as backup human bodies, putting radical longevity ambitions and cloning ethics back into public view.

A new MIT Technology Review report examines why some people still choose cryonic preservation despite its high cost and the vanishingly small odds of ever being brought back

Cryobiologist Greg Fahy has studied rewarmed tissue from his late colleague's brain, which has been stored at −146°C for over a decade. The findings offer more promise for organ transplantation than revival of the dead.

A major randomized trial shows daily multivitamin supplementation measurably slows epigenetic aging, the first rigorous evidence that a common supplement can affect biological age.

Tokyo researchers discovered that polyamines activate different proteins in healthy versus cancerous cells, explaining their paradoxical dual role in longevity and tumor growth.

In an exclusive interview, Jim O'Neill discussed further changes to childhood vaccine recommendations, his Vitalist philosophy on aging, and ARPA-H's $170 million organ-growing program.

MIT Technology Review's daily briefing features an exclusive interview with US Deputy Health Secretary Jim O'Neill on longevity science and vaccine policy, plus the surprising truth about why real heists are nothing like the movies.